Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans

Stem Cells and Development

Volumn 20, Issue 8, 2011, Pages 1297-1308

  Ra, Jeong Chan ^a   Shin, Il Seob ^a   Kim, Sang Han ^b   Kang, Sung Keun ^a   Kang, Byeong Cheol ^c,d   Lee, Hang Young ^a   Kim, Youn Joung ^a   Jo, Jung Youn ^a   Yoon, Eun Ji ^a   Choi, Hyung Jun ^c,d   Kwon, Euna ^d  

^a Stem Cell Research Center   (South Korea)

^b Anyang SAM Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFUSION; KARYOTYPING; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SAFETY; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD INJURY;

ADIPOSE TISSUE; ADULT; ANIMALS; ANTIGENS, SURFACE; CARCINOGENICITY TESTS; CELL DIFFERENTIATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KARYOTYPE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; MIDDLE AGED; NEOPLASMS; SPINAL CORD INJURIES;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79958825416     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0466     Document Type: Article

References (46)

1. Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
2. Erices A, P Conget and JJ Minguell. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242. (Pubitemid 30340601)
3. Zhang Y, C Li, X Jiang, H Li, P Tang and N Mao. (2004). Comparison of mesenchymal stem cells from human placenta and bone marrow. Chin Med J 117:882-887. (Pubitemid 38961684)
4. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228. (Pubitemid 32295155)
5. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
6. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science (New York, N.Y.) 284:143-147. (Pubitemid 29282067)
7. Sen A, YR Lea-Currie, D Sujkowska, DM Franklin, WO Wilkison, YD Halvorsen and JM Gimble. (2001). Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem 81:312-319. (Pubitemid 32298263)
8. Jo JY, SK Kang, IS Choi and JC Ra. (2009). Comparison of neural cell differentiation of human adipose mesenchymal stem cells derived from young and old ages. Dev Reprod 13:227-237.
9. Saito T, J Kuang, B Bittira, A Al-Khaldi and RCJ Chiu. (2002). Xenotransplant cardiac chimera: Immune tolerance of adult stem cells. Ann Thorac Surg 74:19-24; discussion 24. (Pubitemid 34741999)
10. Mouiseddine M, S François, A Semont, A Sache, B Allenet, N Mathieu, J Frick, D Thierry and A Chapel. (2007). Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 80 Spec No 1:S49-S55. (Pubitemid 47517799)
11. Gimble JM, F Guilak and BA Bunnell. (2010). Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1:19.
12. CFR-Code of Federal Regulations Title 21, 2010. www accessdata.fda.gov/ scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm.
13. Maynard FM, MB Bracken, G Creasey, JF Ditunno, WH Donovan, TB Ducker, SL Garber, RJ Marino, SL Stover, CH Tator, RL Waters, JE Wilberger and W Young. (1997). International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord 35:266-274. (Pubitemid 27235039)
14. Brimble SN, X Zeng, DA Weiler, Y Luo, Y Liu, IG Lyons, WJ Freed, AJ Robins, MS Rao and TC Schulz. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13:585-597. (Pubitemid 40052635)
15. Lange C, F Cakiroglu, A Spiess, H Cappallo-Obermann, J Dierlamm and AR Zander. (2007). Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18-26. (Pubitemid 47378788)
16. Meza-Zepeda LA, A Noer, JA Dahl, F Micci, O Myklebost and P Collas. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12:553-563. (Pubitemid 351555134)
17. Loring JF and MS Rao. (2006). Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells (Dayton, Ohio) 24:145-150.
18. Wislet-Gendebien S, P Leprince, G Moonen and B Rogister. (2003). Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci 116:3295-3302. (Pubitemid 37038978)
19. Bonab MM, K Alimoghaddam, F Talebian, SH Ghaffari, A Ghavamzadeh and B Nikbin. (2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14.
20. Briquet A, S Dubois, S Bekaert, M Dolhet, Y Beguin and A Gothot. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica 95:47-56.
21. Imreh MP, K Gertow, J Cedervall, C Unger, K Holmberg, K Szöke, L Csöregh, G Fried, S Dilber, E Blennow and L Ahrlund-Richter. (2006). In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem 99:508-516. (Pubitemid 44435567)
22. Hanson C and G Caisander. (2005). Human embryonic stem cells and chromosome stability. APMIS 113:751-755. (Pubitemid 43934218)
23. Rubio D, J Garcia-Castro, MC Martín, R de la Fuente, JC Cigudosa, ACLloyd andABernad. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039. (Pubitemid 40524580)
24. Rubio D, S Garcia, T De la Cueva, MF Paz, AC Lloyd, A Bernad and J Garcia-Castro. (2008). Human mesenchymal stem cell transformation is associated with a mesenchymalepithelial transition. Exp Cell Res 314:691-698.
25. de la Fuente R, A Bernad, J Garcia-Castro, MC Martin and JC Cigudosa. (2010). Retraction: Spontaneous human adult stem cell transformation. Cancer Res 70:6682.
26. Garcia S, A Bernad, MC Martín, JC Cigudosa, J Garcia-Castro and R de la Fuente. (2010). Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 316:1648-1650.
27. Røsland GV, A Svendsen, A Torsvik, E Sobala, E McCormack, H Immervoll, J Mysliwietz, J Tonn, R Goldbrunner, PE Lønning, R Bjerkvig and C Schichor. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331-5339.
28. Torsvik A, GV Røsland, A Svendsen, A Molven, H Immervoll, E McCormack, PE Lønning, M Primon, E Sobala, J Tonn, R Goldbrunner, C Schichor, J Mysliwietz, TT Lah, H Motaln, S Knappskog and R Bjerkvig. (2010). Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: Putting the research field on track-letter. Cancer Res 70:6393-6396.
29. Bernardo ME, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, AMoretta,DMontagna, R Maccario, R Villa,MGDaidone, OZuffardi and F Locatelli. (2007).Humanbonemarrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149. (Pubitemid 47535900)
30. Kim J, JW Kang, JH Park, Y Choi, KS Choi, KD Park, DH Baek, SK Seong, H Min and HS Kim. (2009). Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 32:117-126.
31. Philippe B, S Luc, P Valérie, R Jérôme, B Alessandra and C Louis. (2010). Culture and use of mesenchymal stromal cells in phase I and II clinical trials. Stem Cells Int 2010:503593.
32. Omori Y, O Honmou, K Harada, J Suzuki, K Houkin and JD Kocsis. (2008). Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 1236:30-38.
33. Furlani D, M Ugurlucan, L Ong, K Bieback, E Pittermann, I Westien, W Wang, C Yerebakan, W Li, R Gaebel, R Li, B Vollmar, G Steinhoff and N Ma. (2009). Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 77:370-376.
34. Beggs KJ, A Lyubimov, JN Borneman, A Bartholomew, A Moseley, R Dodds, MP Archambault, AK Smith and KR McIntosh. (2006). Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15:711-721. (Pubitemid 46095254)
35. Lazarus HM, SE Haynesworth, SL Gerson, NS Rosenthal and AI Caplan. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 16:557-564.
36. Horwitz EM, PL Gordon, WKK Koo, JC Marx, MD Neel, RY McNall, L Muul and T Hofmann. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937. (Pubitemid 34693661)
37. Koç ON, J Day, M Nieder, SL Gerson, HM Lazarus and W Krivit. (2002). Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215-222. (Pubitemid 35023593)
38. Chen S, W Fang, F Ye, Y Liu, J Qian, S Shan, J Zhang, RZ Chunhua, L Liao, S Lin and J Sun. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95. (Pubitemid 38813459)
39. Le Blanc K, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, B Sundberg, ME Bernardo, M Remberger, G Dini, RM Egeler, A Bacigalupo, W Fibbe and O Ringdén. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586. (Pubitemid 351626841)
40. Tolar J, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, S Bell, L Xia, N Zhou,MRiddle, TM Schroeder, JJ Westendorf,RSMcIvor,PCWHogendoorn, KSzuhai,LOseth, B Hirsch, SR Yant, MA Kay, A Peister, DJ Prockop,WE Fibbe and BR Blazar. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (Dayton, Ohio) 25:371-379. (Pubitemid 46232791)
41. Zimmerlin L, AD Donnenberg, JP Rubin, RJ Landreneau, P Basse and VS Donnenberg. (2011). Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Engineering Part A 17:93-106.
42. Vilalta M, IR Dégano, J Bagó , D Gould, M Santos, M García-Arranz, R Ayats, C Fuster, Y Chernajovsky, D García-Olmo, N Rubio and J Blanco. (2008). Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 17:993-1003.
43. Izadpanah R, D Kaushal, C Kriedt, F Tsien, B Patel, J Dufour and BA Bunnell. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68:4229-4238.
44. Kirshblum S, S Millis, W McKinley and D Tulsky. (2004). Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil 85:1811-1817. (Pubitemid 39441139)
45. Crozier KS, V Graziani, JF Ditunno and GJ Herbison. (1991). Spinal cord injury: Prognosis for ambulation based on sensory examination in patients who are initially motor complete. Arch Phys Med Rehabil 72:119-121.
46. Waters RL, RH Adkins, JS Yakura and I Sie. (1994). Motor and sensory recovery following incomplete tetraplegia. Arch Phys Med Rehabil 75:306-311. (Pubitemid 24099564)